Plasma Protein (e.g., Albumin): Liver synthesizes, kidneys maintain albumin, which binds drugs in blood.
High Protein Binding: Decreased free drug, lower distribution, acts as a reservoir for prolonged effect (e.g., phenytoin for seizures).
Low Protein Binding: Increased free drug, higher distribution (e.g., in CKD or liver disease where albumin levels are low, leading to toxic side effects).
Solubility of Drug
Hydrophobic, Small, Nonpolar Drugs: High distribution, easily pass through membranes.
Hydrophilic, Large, Polar Drugs: Low distribution, tend to stay in the blood.
Volume of Distribution (Vd)
Represents the theoretical volume in which a drug is distributed in the body.
Low Volume of Distribution: Drug concentrates in plasma (high protein binding, low capillary permeability, hydrophilic).
Medium Volume of Distribution: Drug present in plasma and interstitial fluid.
High Volume of Distribution: Drug extensively distributed in plasma, interstitial fluid, and intracellular fluid (nonpolar, hydrophobic, not protein-bound).
Clinical Examples
Warfarin: Low Vd (~8L), concentrates in plasma, important for its role as a blood thinner.
Chloroquine: Very high Vd (~150,000L), disperses widely, used for malaria.
Calculation of Vd
Formula: Vd = (Bioavailability x Dose) / Plasma Concentration
Example Calculation: For a drug with a 2,000 mg dose, peak plasma concentration of 28.5, and IV administration (bioavailability = 1), Vd = 2000/28.5 ≈ 70L or 1L/kg if patient's weight is 70kg.
Summary
Distribution is influenced by multiple factors including blood flow, capillary permeability, protein binding, and solubility.
Volume of distribution (Vd) helps determine how widely a drug disperses in the body.